Tirzepatide 10MG (GLP-2 "TIRZ")
Tirzepatide is a synthetic 39-amino acid peptide engineered as a dual receptor agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. For Tirzepatide, each vial is labeled 10MG, molecular formula C225H348N48O68, molecular weight approx. 4,813.5 Da, CAS 2023788-19-2.
Published laboratory work with Tirzepatide has examined dual incretin receptor pharmacology, glucose and insulin signaling, adipose and hepatic metabolic pathway. Each lot is manufactured under sterile conditions, lyophilized in single-use research vials, and labeled with its production lot for traceability.
Supplied for in-vitro laboratory research use only. Not for human or veterinary consumption, administration, diagnostic or therapeutic use.
Tirzepatide-class dual agonist studied for GIP and GLP-1 receptor pathways.
Browse all GLP class research peptides, or read the GLP receptor agonist research overview.
Background reading on this compound in the ENOS Lab Notes: The GLP Peptide Family Explained and CagriSema: Amylin and GLP-1 Research Landscape.
Background reading: how to read a certificate of analysis, why purity and identity are separate tests and storage and handling guidance.
| Vial | Price | Price per mg |
|---|---|---|
| 10MG (this page) | $68.20 | $6.82/mg |
| 20MG | $95.20 | $4.76/mg |
- Ships from Arizona
- Free shipping through Nov 14
- Zelle, Venmo, Cash App, USDT
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.
Compound identity
Listed on the storefront as GLP-2 "TIRZ". The compound information for this research vial is below.
- Compound name
- Tirzepatide
- Also known as
- Tirzepatide, LY3298176, GLP-2 TIRZ, Dual GIP/GLP-1 agonist
- Molecular formula
- C225H348N48O68
- Molecular weight
- Approximately 4,813.5 Da
- CAS number
- 2023788-19-2
- Vial size
- 10MG
Product Information
Research DatasheetProduct Overview
Tirzepatide is a synthetic 39-amino acid peptide engineered as a dual receptor agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In laboratory research it is used to investigate incretin biology, glucose homeostasis, insulin signaling, adipose metabolism, and dual receptor pharmacology. Manufactured under sterile conditions. For laboratory research use only. Not for human or veterinary use.
Molecular Profile
Research Applications
- ◆Dual incretin receptor pharmacology
- ◆Glucose and insulin signaling research
- ◆Adipose and hepatic metabolic pathway research
- ◆Energy homeostasis receptor studies
- ◆Receptor binding and activation studies
- ◆Metabolic disease laboratory models
- ◆Peptide pharmacokinetics and stability research
- ◆Comparative incretin analog research
Quality Standards
Lab documentation: available on request, info@enosusa.com
For in-vitro research use only. Not for human consumption, diagnosis, or treatment.
Tirzepatide-class dual agonist studied for GIP and GLP-1 receptor pathways. All ENOS research vials are lyophilized, sealed under sterile conditions, and shipped with cold-chain packaging where appropriate.
- ◆Dual receptor studies
- ◆Metabolic research
- ◆Widely investigated
You may also like
GLP-2 "TIRZ" · 20MG
Tirzepatide 20MG research vial, GIP and GLP-1 receptor dual agonist.
GLP-3 "RET" · 10MG
Retatrutide 10MG research vial, GIP, GLP-1 and glucagon receptor triple agonist.
GLP-3 "RET" · 20MG
Retatrutide 20MG research vial, GIP, GLP-1 and glucagon receptor triple agonist.
GLP-3 "RET" · 30MG
Retatrutide 30MG research vial, GIP, GLP-1 and glucagon receptor triple agonist.